Turning Point: The Quest for a Cure
BrightFocus Foundation is a presentation partner for Turning Point, an award-winning documentary capturing the drama and dedication of scientists and clinical trial volunteers who are working to make Alzheimer’s a distant memory.
Working with Gates Ventures and public and private sector leaders, BrightFocus has screened the film nationally and internationally for community audiences, health care and scientific groups, and policymakers.
“Turning Point is an excellent documentary that gives us an inside look at the doctors, scientists, and patients who are working to uncover the mysteries of Alzheimer’s disease through clinical trials. Everybody should see this film.”- Bill Gates
The Quest for an Alzheimer’s Cure
Watch Now
Rent or purchase the full documentary, Turning Point: The Quest for a Cure, on one of these trusted streaming platforms.
Funded by:
The film was funded through a grant by Eli Lilly and Company to Volunteers of America. PCH Films retained full editorial control of all content and messaging in the film.
Related Resources
Related Resources & Information
Therapeutic TV for Alzheimer’s: What the Research Shows
In this episode, Allyson Schrier shares how research following her experience caring for her husband with dementia led her to create a streaming service designed to calm, engage, and support people living with memory loss.
The SPRING Trial: Targeting Gum Bacteria in Alzheimer’s
Dr. Michael J. Detke of Lighthouse Pharma explains the SPRING clinical trial and how the investigational oral drug LHP588 is being studied to reduce bacteria-related brain damage.
Is It Alzheimer’s? Recognizing Early Signs & Symptoms
Behavioral neurologist Dr. Sharon Cohen explains the early signs and symptoms of Alzheimer’s disease, medical conditions that can mimic dementia, and how to start a conversation with your doctor.
Alzheimer’s Clinical Trials 2026: An Insider’s Look with Dr. Jeffrey Cummings
Join Dr. Jeffrey Cummings as he shares an insider’s overview of the evolving Alzheimer’s treatment development pipeline.
Understanding Your APOE Status: Genetics and Alzheimer’s Risk
About 25% of people carry one copy of the APOE4 gene, the strongest genetic risk factor for developing Alzheimer’s. Dr. Eric M. Reiman explains what genetic testing can—and cannot—tell you, including why APOE4 signals increased risk but does not mean a definite Alzheimer’s diagnosis.
Expanding the Alzheimer’s Treatment Landscape: A 2026 Forecast
Learn about the treatments landscape for Alzheimer’s in 2026 and beyond.
Leqembi and Kisunla: Your Questions Answered
A leading neurologist answers your most common questions about what Leqembi and Kisunla can realistically do, including effectiveness, safety, eligibility, infusion logistics, cost, and access.
Alzheimer’s Risk Reduction: Nutrition & Lifestyle
There are healthy actions people can take to improve and maintain health, no matter what conditions they may be facing.
The AHEAD Study: Can Alzheimer’s Be Prevented or Slowed Before Symptoms Begin?
Join Dr. Joshua Grill as he shares details about the AHEAD Study.